COTL1 and breast carcinoma: One interesting regulatory mechanism involves the de-repression of COTL1 expression by genetic silencing of different microRNA species, such as microRNA-30c-5p in breast cancer (Pei et al., 2020) and microRNA-506-3p in lung cancer (Guo et al., 2017).